Who Owns Unicycive Therapeutics Stock?
NASDAQ: UNCYHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 42.27%
- Held by insiders
- 2.26%
- Institutional holders
- 111
- Institutions 42.3%
- Insiders 2.3%
- Public and other 55.5%
Who owns Unicycive Therapeutics stock?
Institutional investors own about 42.3% of Unicycive Therapeutics's shares, spread across 111 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 2.26% of UNCY.
The largest institutional holders are Blackrock Inc. (5.07%), Nantahala Capital Management, LLC (5.03%) and Vanguard Capital Management LLC (3.85%). Together, the top 10 institutions control 28.2% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their UNCY positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of UNCY
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 1.41M | 5.07% | +3836.7% |
| Nantahala Capital Management, LLC | 1.40M | 5.03% | +49.2% |
| Vanguard Capital Management LLC | 1.07M | 3.85% | +32.0% |
| Octagon Capital Advisors LP | 1.00M | 3.59% | 0.0% |
| Geode Capital Management, LLC | 564.02K | 2.02% | +176.8% |
| Vivo Capital, LLC | 550.00K | 1.97% | -69.3% |
| Marshall Wace LLP | 547.86K | 1.97% | +253.6% |
| Logos Global Management LP | 473.56K | 1.70% | 0.0% |
| State Street Corporation | 450.16K | 1.62% | +462.5% |
| Diametric Capital, Lp | 374.13K | 1.34% | +365.6% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of UNCY
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 805.72K | 2.89% |
| iShares Trust-iShares Russell 2000 ETF | 606.92K | 2.18% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 268.85K | 0.97% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 240.02K | 0.86% |
| iShares Trust-iShares Russell 2000 Growth ETF | 203.29K | 0.73% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 105.74K | 0.38% |
| iShares Trust-iShares Micro-Cap ETF | 81.44K | 0.29% |
| Dimensional ETF Trust-Dimensional U.S. Small Cap ETF | 67.83K | 0.24% |
| SPDR-EUROPE-SSgA SPDR ETFS Europe I-State Street SPDR Russell 2000 US | 63.60K | 0.23% |
| SCHWAB CAPITAL TRUST-Schwab Small-Cap Index Fund | 54.84K | 0.20% |
Frequently asked questions
Who is the largest shareholder of Unicycive Therapeutics?
Blackrock Inc. is the largest institutional shareholder of UNCY, owning 5.07% of shares outstanding (1.41M shares) as of its latest 13F filing.
What percentage of Unicycive Therapeutics is owned by institutions?
Institutions own about 42.3% of UNCY shares and 43.2% of the public float.
How much of Unicycive Therapeutics do insiders own?
Insiders, such as officers and directors, own about 2.26% of UNCY shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.